Table 2.
Treatment | Efferent ductules + epididymis |
Ventral prostate (mg/100 g BW) | SV + CG (mg/100 g BW) | |
---|---|---|---|---|
Left (mg) | Right (mg) | |||
Intact control | 170.6 ± 4.7 | 170.0 ± 2.8 | 257.1 ± 8.0 | 481.1 ± 24.0 |
Bilateral ligation | 133.3 ± 2.7* | 136.7 ± 4.8* | 172.6 ± 16.3 | 428.3 ± 35.7 |
Unilateral ligation | 161.6 ± 5.8 | 110.6 ± 5.9** | 203.1 ± 11.1 | 398.8 ± 20.3 |
Unilateral castration | 169.5 ± 9.4 | 122.9 ± 5.5** | 252.9 ± 35.8 | 464.2 ± 18.1 |
Bilateral castration | 55.4 ± 0.9* | 60.3 ± 3.2* | 26.3 ± 1.2* | 67.7 ± 4.3* |
Sham operation | 187.8 ± 10.9 | 161.5 ± 17.8 | 196.9 ± 27.2 | 440.5 ± 14.4 |
Bicastration + corn oil (control) | 56.8 ± 0.2* | 56.6 ± 5.7* | 25.0 ± 0.7* | 74.8 ± 2.9* |
Bicastration + T (1 mg) | 148.4 ± 2.9* | 148.8 ± 4.9* | 348.7 ± 38.6* | 950.2 ± 33.0* |
Bicastration + T (5 mg) | 147.5 ± 10.8* | 147.5 ± 13.2* | 379.6 ± 11.3* | 929.2 ± 3.2* |
Bicastration + DHT (5 mg) | 147.1 ± 11.9* | 142.8 ± 8.2* | 362.4 ± 19.4* | 866.8 ± 10.8* |
Bicastration + E2 (75 μg) | 63.8 ± 4.2* | 81.7 ± 13.7* | 42.5 ± 3.6* | 103.2 ± 15.5* |
Bicastration + E2 (400 μg) | 69.1 ± 7.6* | 90.7 ± 18.5* | 51.0 ± 9.4* | 104.6 ± 9.0* |
Bicastration + T (5 mg) + E2 (400 μg) | 157.6 ± 4.5 | 169.8 ± 5.1 | 466.8 ± 18.5* | 1206.9 ± 56.7* |
T, testosterone; E2, 17β-estradiol.
P ≤ 0.05 compared with intact control;
P ≤ 0.05 compared with castrated control.